yh14617
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01507038)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- LAG3INHIBITOR
LAG3 inhibitor
inhibitor - TIM3
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- yh14617
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01507038 | Phase 2 | Dec 1, 2011 | Korea University, Peptron, Inc., Yuhan Pharmaceutical Company |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Peptron, Inc. | For profit | 1 | 0 | 1 | 2011 |
| Yuhan Pharmaceutical Company | For profit | 1 | 1 | 1 | 2011 |
3 organizations
Page 1 / 1